Live Attenuated Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Live Attenuated Vaccines Market covers analysis by Type (Viral and Bacterial); End User (Hospitals, Clinics, Research Institutes, and Other End Users) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00004591
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION
Live attenuated vaccines are produced from the pathogens which are weakened at such a level that they can grow in vaccinated person but causes no or mild disease formation. These vaccines helps in creating the immune response which protects the vaccinated individual from acquiring the same disease. The WHO recommended vaccines such as BCG, polio vaccine, measles, rotavirus and yellow fever are made by attenuation.

MARKET DYNAMICS
The live attenuated vaccines market is expected to grow during the forecast period due to awareness regarding vaccination, hike in funding by government to and steps taken to make vaccination compulsory for children. Furthermore, the growing occurrence of infectious diseases are providing the opportunity to market.

MARKET SCOPE
The "Global Live Attenuated Vaccines Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of live attenuated vaccines market with detailed market segmentation by type, end user and geography. The global live attenuated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading live attenuated vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global live attenuated vaccines market is segmented on the basis of type and end user. Based on type, the market is classified as viral and bacterial. On the basis of end user, the market is classified as hospitals, clinics, research institutes and other end users. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global live attenuated vaccines market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The live attenuated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting live attenuated vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the live attenuated vaccines market in these regions.

Live Attenuated Vaccines Market Report Analysis

Live Attenuated Vaccines Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum institute of India Pvt. Ltd.
  • CSL Limited

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Type
  • Viral and Bacterial
Market Segment By End User
  • Hospitals
  • Clinics
  • Research Institutes
  • Other End Users
MARKET PLAYERS

The reports cover key developments in the live attenuated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from live attenuated vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for live attenuated vaccines market in the global market. Below mentioned is the list of few companies engaged in the live attenuated vaccines market.

The report also includes the profiles of key live attenuated vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum institute of India Pvt. Ltd.
  • CSL Limited
  • Vivaldi Biosciences Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Live Attenuated Vaccines Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Viral and Bacterial
By End User
  • Hospitals
  • Clinics
  • Research Institutes
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • BioDiem
  • AstraZeneca
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum institute of India Pvt. Ltd.
  • CSL Limited
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..   

    The List of Companies

    1. Emergent BioSolutions Inc.
    2. GlaxoSmithKline plc
    3. BioDiem
    4. AstraZeneca
    5. Merck & Co., Inc.
    6. Pfizer Inc.
    7. Sanofi
    8. Serum institute of India Pvt. Ltd.
    9. CSL Limited
    10. Vivaldi Biosciences Inc.